#Dose

halvorz ¯\_(ツ)_/¯

halvorz

oh man this is phenomenal, there is so much herehttps://twitter.com/Timothee_B/status/1360981420836061186 answers a lot of questions I've had that previous papers on these topics failed to answer including pretty strong confirmation

chakkaravarthy

drkrvcvijay

#CovidVaccine thread.@rameshlaus @sumanthraman @priyankathiru @dhanyarajendran US,UK, Canada had started their COVID vaccinations as expected .Probably our Government may get the vaccinations by January and reach private market by March for

Linsey Marr

linseymarr

Airborne Transmission of SARS-CoV-2: What We Know https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab039/6103221#.YAYRMJvSJ4Q.twitter Paper from our @theNASEM #EnviroHealthMatters workshop. Source-to-dose framework, like for p

zeynep tufekci

zeynep

If we move fast with trials for a single-dose vaccine, we might be able to double the number of people we can quickly vaccinate—ending this crisis sooner, helping with vaccine

John P. Hussman, Ph.D.

hussmanjp

2/ My reading of the Pfizer results is that protection emerges after about 10 days (which is about where one would expect people to be come seropositive) and flattens after

Rupert Pearse

rupert_pearse

The vaccine conversation took an unexpected turn this week with the decision to prioritise first doses for people who haven't been vaccinated over second doses for those who have. Staff

Eric Feigl-Ding

DrEricDing

Breaking—FDA analysis of the Pfizer/BioNTech vaccine data found that the #COVID19 vaccine worked well regardless of a volunteer’s race, weight or age, and offered strong immunity protection within 10 days

Dave Blake, PhD

_stah

The one dose, two dose, issue, for my followers. No answers from me - just pointers to cogent arguments on either side. 1/ A thread from a vaccinologist. He points

Lauren Murphey

LRMurphh

Update!As many of you know, I enrolled in the Moderna phase 3 vaccine trial back in August. Now that Moderna has been issues their EUA, I have been unblinded and

Robert Peston

Peston

The big point about the first dose of the Oxford/AstraZeneca vaccine is that it massively reduces the risk of serious disease and hospitalisations. In the trials, no one given the

Michael Lin, PhD-MD

michaelzlin

1/nExciting findings on the AZN vaccine:1. big trial (17k)2. tested 1 dose vs 2 doses (assessing 1-dose efficacy correctly, unlike Pfizer), and short vs long delay to dose 23. first

Casey Hohman

caseyhohman

This past Thursday, I volunteered to work at the State Farm Stadium COVID-19 vaccination center in Glendale, Arizona. I signed up, knowing that if I completed an 8-hour volunteer shift,

Shane Crotty

profshanecrotty

SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus) adenoviral (Ad) vector COVID vaccine. The clinical trial data look really

Rajeev Venkayya MD

rvenkayya

THREADThere’s much debate around the UK's recommended use of the AZ vaccine with a two-dose schedule and flexible timing of second dose. Some thoughts on the AZ recommendation (not Pfizer)

ᕕ( ᐛ )ᕗ

amiracle315

Forever grateful to have the opportunity to receive the second dose of the Pfizer vaccine so I can continue to protect my patients, friends, and loved ones!!! https://twitter.com/amiracle315/status/1346983971268284422 I got

Mac n’ Chise 🧬🧫🦠

sailorrooscout

A very encouraging study done on our mRNA vaccines! Pfizer and Moderna vaccines provided strong immune responses against variant B.1.351 first identified in South Africa in those who recovered from

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.